These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3468899)

  • 1. Dose-dependence of the nifedipine/digoxin interaction?
    Hutt HJ; Kirch W; Dylewicz P; Ohnhaus EE
    Arch Toxicol Suppl; 1986; 9():209-12. PubMed ID: 3468899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependence of the nifedipine-digoxin interaction?
    Kirch W; Hutt HJ; Dylewicz P; Gräf KJ; Ohnhaus EE
    Clin Pharmacol Ther; 1986 Jan; 39(1):35-9. PubMed ID: 3943268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrendipine/digoxin interaction.
    Kirch W; Logemann C; Heidemann H; Santos SR; Ohnhaus EE
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S74-5. PubMed ID: 2455147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals.
    Kirch W; Logemann C; Heidemann H; Santos SR; Ohnhaus EE
    Eur J Clin Pharmacol; 1986; 31(4):391-5. PubMed ID: 3816917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nifedipine on serum digoxin concentrations in patients.
    Schwartz JB; Raizner A; Akers S
    Am Heart J; 1984 Apr; 107(4):669-73. PubMed ID: 6702561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies of nifedipine and digoxin co-administration.
    Koren G; Zylber-Katz E; Granit L; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):39-42. PubMed ID: 3957488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between digoxin and nifedipine at steady state in patients with atrial fibrillation.
    Kleinbloesem CH; van Brummelen P; Hillers J; Moolenaar AJ; Breimer DD
    Ther Drug Monit; 1985; 7(4):372-6. PubMed ID: 3909533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of the calcium antagonist RO 40-5967 with digoxin.
    Siepmann M; Kleinbloesem C; Kirch W
    Br J Clin Pharmacol; 1995 May; 39(5):491-6. PubMed ID: 7669484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of mutual pharmacokinetic interaction between cerivastatin, a new HMG-CoA reductase inhibitor, and digoxin in healthy normocholesterolemic volunteers.
    Weber P; Lettieri JT; Kaiser L; Mazzu AL
    Clin Ther; 1999 Sep; 21(9):1563-75. PubMed ID: 10509851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions with nitrendipine.
    Kirch W; Hutt HJ; Heidemann H; Rämsch K; Janisch HD; Ohnhaus EE
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S982-5. PubMed ID: 6085389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interactions of digoxin and the nonsteroidal anti-inflammatory drugs, acetylsalicylic acid and nifedipine].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1982 Dec; 37(49):1475-6. PubMed ID: 7184005
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-interaction between nifedipine and digoxin.
    Pedersen KE; Madsen JL; Klitgaard NA; Kjoer K; Hvidt S
    Dan Med Bull; 1986 Apr; 33(2):109-10. PubMed ID: 3709238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.
    Brown DD; Schmid J; Long RA; Hull JH
    J Clin Pharmacol; 1985; 25(5):360-4. PubMed ID: 4031112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between nifedipine and digoxin in rats.
    Maitai CK; Njoroge DK; Munenge RW
    East Afr Med J; 1995 Jan; 72(1):75-6. PubMed ID: 7781564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal assessment of a P-glycoprotein-mediated drug interaction of valspodar on digoxin.
    Kovarik JM; Rigaudy L; Guerret M; Gerbeau C; Rost KL
    Clin Pharmacol Ther; 1999 Oct; 66(4):391-400. PubMed ID: 10546923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of using nifedipine by patients with chronic congestive heart failure treated with digoxin and furosemide].
    Markiewicz K; Górski L; Cholewa M; Gawor Z; Dryjański T
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):461-5. PubMed ID: 2277789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet aggregation by oral digoxin and reversal with nifedipine.
    Ware JA; Schwartz JB; Horak JK; Solis RT
    J Cardiovasc Pharmacol; 1985; 7(2):262-6. PubMed ID: 2581078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic basis of nifedipine-digoxin interaction: a commentary.
    Kokwaro GO
    East Afr Med J; 1995 Oct; 72(10):684-7. PubMed ID: 8904054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
    Dockens RC; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.